Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02512497
Title Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ohio State University Comprehensive Cancer Center
Indications

T-cell large granular lymphocyte leukemia

cutaneous T cell lymphoma

lymphoid leukemia

peripheral T-cell lymphoma

Therapies

Romidepsin

Busulfan + Fludarabine + Romidepsin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.